Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 1811 entries
Sorted by: Best Match Show Resources per page
Synthesis of CaCO3 Nanobelts for Drug Delivery in Cancer Therapy.

Nanoscale research letters

Sun D, Peng H, Wang S, Zhu D.
PMID: 26055480
Nanoscale Res Lett. 2015 Dec;10(1):948. doi: 10.1186/s11671-015-0948-6. Epub 2015 May 27.

Nanobelt carriers have demonstrated some advantages such as good biocompatibility, biodegradability, and strain-accommodating properties. We prepared an optimized nanobelt carrier formulation for drug (etoposide) as an oral delivery system and estimated the potential of calcium carbonate (CaCO3) nanobelts. The...

Cite
Sun D, Peng H, Wang S, et al. Synthesis of CaCO3 Nanobelts for Drug Delivery in Cancer Therapy. Nanoscale Res Lett. 2015;10(1):948doi: 10.1186/s11671-015-0948-6.
Sun, D., Peng, H., Wang, S., & Zhu, D. (2015). Synthesis of CaCO3 Nanobelts for Drug Delivery in Cancer Therapy. Nanoscale research letters, 10(1), 948. https://doi.org/10.1186/s11671-015-0948-6
Sun, Dongmei, et al. "Synthesis of CaCO3 Nanobelts for Drug Delivery in Cancer Therapy." Nanoscale research letters vol. 10,1 (2015): 948. doi: https://doi.org/10.1186/s11671-015-0948-6
Sun D, Peng H, Wang S, Zhu D. Synthesis of CaCO3 Nanobelts for Drug Delivery in Cancer Therapy. Nanoscale Res Lett. 2015 Dec;10(1):948. doi: 10.1186/s11671-015-0948-6. Epub 2015 May 27. PMID: 26055480; PMCID: PMC4456597.
Copy Download .nbib Format: NLM
The Relation between Histopathologic Findings on Surgical Specimen and Outcomes in Patients with N2 Positive Stage IIIA Non-Small Cell Lung Cancer Receiving Preoperative Concurrent Radiochemotherapy and Surgery.

Cancer research and treatment

Kim BK, Kim KJ, Ahn YC, Lim DH, Park W, Han J, Park K, Kim KM, Kim J, Shim YM.
PMID: 26680981
Cancer Res Treat. 2003 Dec;35(6):497-501. doi: 10.4143/crt.2003.35.6.497.

PURPOSE: To evaluate the prognostic implication of histopathologic findings on the surgical specimens of N2 positive stage IIIA non-small cell lung cancer (NSCLC) patients who were treated with preoperative concurrent radiochemotherapy (CRCT) and surgery.MATERIALS AND METHODS: From May 1997...

Cite
Kim BK, Kim KJ, Ahn YC, et al. The Relation between Histopathologic Findings on Surgical Specimen and Outcomes in Patients with N2 Positive Stage IIIA Non-Small Cell Lung Cancer Receiving Preoperative Concurrent Radiochemotherapy and Surgery. Cancer Res Treat. 2003;35(6):497-501doi: 10.4143/crt.2003.35.6.497.
Kim, B. K., Kim, K. J., Ahn, Y. C., Lim, D. H., Park, W., Han, J., Park, K., Kim, K. M., Kim, J., & Shim, Y. M. (2003). The Relation between Histopathologic Findings on Surgical Specimen and Outcomes in Patients with N2 Positive Stage IIIA Non-Small Cell Lung Cancer Receiving Preoperative Concurrent Radiochemotherapy and Surgery. Cancer research and treatment, 35(6), 497-501. https://doi.org/10.4143/crt.2003.35.6.497
Kim, Bo Kyong, et al. "The Relation between Histopathologic Findings on Surgical Specimen and Outcomes in Patients with N2 Positive Stage IIIA Non-Small Cell Lung Cancer Receiving Preoperative Concurrent Radiochemotherapy and Surgery." Cancer research and treatment vol. 35,6 (2003): 497-501. doi: https://doi.org/10.4143/crt.2003.35.6.497
Kim BK, Kim KJ, Ahn YC, Lim DH, Park W, Han J, Park K, Kim KM, Kim J, Shim YM. The Relation between Histopathologic Findings on Surgical Specimen and Outcomes in Patients with N2 Positive Stage IIIA Non-Small Cell Lung Cancer Receiving Preoperative Concurrent Radiochemotherapy and Surgery. Cancer Res Treat. 2003 Dec;35(6):497-501. doi: 10.4143/crt.2003.35.6.497. PMID: 26680981.
Copy Download .nbib Format: NLM
A Literature Review and Case Report of Metastatic Pure Choriocarcinoma.

Case reports in oncological medicine

Lin D, Tan AJ, Singh-Rai R.
PMID: 26649213
Case Rep Oncol Med. 2015;2015:345018. doi: 10.1155/2015/345018. Epub 2015 Nov 16.

In 2012, testicular cancer was estimated to account for 940 disability adjusted life years in Australia; of these, 450 were years lost due to premature death and 500 were years of healthy life lost due to disease, disability, or...

Cite
Lin D, Tan AJ, Singh-Rai R. A Literature Review and Case Report of Metastatic Pure Choriocarcinoma. Case Rep Oncol Med. 2015;2015:345018doi: 10.1155/2015/345018.
Lin, D., Tan, A. J., & Singh-Rai, R. (2015). A Literature Review and Case Report of Metastatic Pure Choriocarcinoma. Case reports in oncological medicine, 2015345018. https://doi.org/10.1155/2015/345018
Lin, Diwei, et al. "A Literature Review and Case Report of Metastatic Pure Choriocarcinoma." Case reports in oncological medicine vol. 2015 (2015): 345018. doi: https://doi.org/10.1155/2015/345018
Lin D, Tan AJ, Singh-Rai R. A Literature Review and Case Report of Metastatic Pure Choriocarcinoma. Case Rep Oncol Med. 2015;2015:345018. doi: 10.1155/2015/345018. Epub 2015 Nov 16. PMID: 26649213; PMCID: PMC4663315.
Copy Download .nbib Format: NLM
26,26,26,27,27,27-Hexadeuterated-1,25-Dihydroxyvitamin D3 (1,25D-d6) As Adjuvant of Chemotherapy in Breast Cancer Cell Lines.

Cancers

Seoane S, Bermudez MA, Sendon-Lago J, Martinez-Ordoñez A, Abdul-Hadi S, Maestro M, Mouriño A, Perez-Fernandez R.
PMID: 24378752
Cancers (Basel). 2013 Dec 27;6(1):67-78. doi: 10.3390/cancers6010067.

It has been demonstrated that 1,25-dihydroxyvitamin D3 (1,25D) and some of its analogues have antitumor activity. 1,25D labeled with deuterium (26,26,26,27,27,27-hexadeuterated 1a,25-dihydroxyvitamin D3, or 1,25D-d6) is commonly used as internal standard for 1,25D liquid chromatography-mass spectrometry (LC-MS) quantification. In...

Cite
Seoane S, Bermudez MA, Sendon-Lago J, et al. 26,26,26,27,27,27-Hexadeuterated-1,25-Dihydroxyvitamin D3 (1,25D-d6) As Adjuvant of Chemotherapy in Breast Cancer Cell Lines. Cancers (Basel). 2013;6(1):67-78doi: 10.3390/cancers6010067.
Seoane, S., Bermudez, M. A., Sendon-Lago, J., Martinez-Ordoñez, A., Abdul-Hadi, S., Maestro, M., Mouriño, A., & Perez-Fernandez, R. (2013). 26,26,26,27,27,27-Hexadeuterated-1,25-Dihydroxyvitamin D3 (1,25D-d6) As Adjuvant of Chemotherapy in Breast Cancer Cell Lines. Cancers, 6(1), 67-78. https://doi.org/10.3390/cancers6010067
Seoane, Samuel, et al. "26,26,26,27,27,27-Hexadeuterated-1,25-Dihydroxyvitamin D3 (1,25D-d6) As Adjuvant of Chemotherapy in Breast Cancer Cell Lines." Cancers vol. 6,1 (2013): 67-78. doi: https://doi.org/10.3390/cancers6010067
Seoane S, Bermudez MA, Sendon-Lago J, Martinez-Ordoñez A, Abdul-Hadi S, Maestro M, Mouriño A, Perez-Fernandez R. 26,26,26,27,27,27-Hexadeuterated-1,25-Dihydroxyvitamin D3 (1,25D-d6) As Adjuvant of Chemotherapy in Breast Cancer Cell Lines. Cancers (Basel). 2013 Dec 27;6(1):67-78. doi: 10.3390/cancers6010067. PMID: 24378752; PMCID: PMC3980618.
Copy Download .nbib Format: NLM
Caspase-dependent drug-induced apoptosis is regulated by cell surface sialylation in human B-cell lymphoma.

Oncology letters

Suzuki O, Abe M, Hashimoto Y.
PMID: 26622554
Oncol Lett. 2015 Aug;10(2):687-690. doi: 10.3892/ol.2015.3320. Epub 2015 Jun 04.

The important role of sialic acid in various biological phenomena is well-established. In order to further clarify the role of sialic acid in cell death induced by various stimuli, the present study compared the cell survival of the HBL-2...

Cite
Suzuki O, Abe M, Hashimoto Y. Caspase-dependent drug-induced apoptosis is regulated by cell surface sialylation in human B-cell lymphoma. Oncol Lett. 2015;10(2):687-690doi: 10.3892/ol.2015.3320.
Suzuki, O., Abe, M., & Hashimoto, Y. (2015). Caspase-dependent drug-induced apoptosis is regulated by cell surface sialylation in human B-cell lymphoma. Oncology letters, 10(2), 687-690. https://doi.org/10.3892/ol.2015.3320
Suzuki, Osamu, et al. "Caspase-dependent drug-induced apoptosis is regulated by cell surface sialylation in human B-cell lymphoma." Oncology letters vol. 10,2 (2015): 687-690. doi: https://doi.org/10.3892/ol.2015.3320
Suzuki O, Abe M, Hashimoto Y. Caspase-dependent drug-induced apoptosis is regulated by cell surface sialylation in human B-cell lymphoma. Oncol Lett. 2015 Aug;10(2):687-690. doi: 10.3892/ol.2015.3320. Epub 2015 Jun 04. PMID: 26622554; PMCID: PMC4508975.
Copy Download .nbib Format: NLM
Molecular Profiling of Refractory Adrenocortical Cancers and Predictive Biomarkers to Therapy.

Biomarkers in cancer

Millis SZ, Ejadi S, Demeure MJ.
PMID: 26715866
Biomark Cancer. 2015 Dec 17;7:69-76. doi: 10.4137/BIC.S34292. eCollection 2015.

PURPOSE: Current first-line chemotherapy for patients with metastatic adrenocortical cancer (ACC) includes doxorubicin, etoposide, cisplatin, and mitotane with a reported response rate of only 23.2%. New therapeutic leads for patients with refractory tumors are needed; there is no standard...

Cite
Millis SZ, Ejadi S, Demeure MJ. Molecular Profiling of Refractory Adrenocortical Cancers and Predictive Biomarkers to Therapy. Biomark Cancer. 2015;7:69-76doi: 10.4137/BIC.S34292.
Millis, S. Z., Ejadi, S., & Demeure, M. J. (2015). Molecular Profiling of Refractory Adrenocortical Cancers and Predictive Biomarkers to Therapy. Biomarkers in cancer, 769-76. https://doi.org/10.4137/BIC.S34292
Millis, Sherri Z, et al. "Molecular Profiling of Refractory Adrenocortical Cancers and Predictive Biomarkers to Therapy." Biomarkers in cancer vol. 7 (2015): 69-76. doi: https://doi.org/10.4137/BIC.S34292
Millis SZ, Ejadi S, Demeure MJ. Molecular Profiling of Refractory Adrenocortical Cancers and Predictive Biomarkers to Therapy. Biomark Cancer. 2015 Dec 17;7:69-76. doi: 10.4137/BIC.S34292. eCollection 2015. PMID: 26715866; PMCID: PMC4686344.
Copy Download .nbib Format: NLM
Outcomes of adult medulloblastoma treated with a multimodality approach: A tertiary cancer center experience.

South Asian journal of cancer

Mallick S, Gandhi AK, Benson R, Sharma DN, Haresh KP, Gupta S, Julka PK, Rath GK.
PMID: 26981508
South Asian J Cancer. 2015 Oct-Dec;4(4):174-8. doi: 10.4103/2278-330X.175954.

OBJECTIVES: Adult medulloblastoma (AMB) is a rare central nervous system tumor. We aimed to analyze the treatment outcomes of AMB treated at our institute with surgery followed by craniospinal irradiation (CSI) and adjuvant chemotherapy.METHODS: We retrospectively evaluated the treatment...

Cite
Mallick S, Gandhi AK, Benson R, et al. Outcomes of adult medulloblastoma treated with a multimodality approach: A tertiary cancer center experience. South Asian J Cancer. 2015;4(4):174-8doi: 10.4103/2278-330X.175954.
Mallick, S., Gandhi, A. K., Benson, R., Sharma, D. N., Haresh, K. P., Gupta, S., Julka, P. K., & Rath, G. K. (2015). Outcomes of adult medulloblastoma treated with a multimodality approach: A tertiary cancer center experience. South Asian journal of cancer, 4(4), 174-8. https://doi.org/10.4103/2278-330X.175954
Mallick, Supriya, et al. "Outcomes of adult medulloblastoma treated with a multimodality approach: A tertiary cancer center experience." South Asian journal of cancer vol. 4,4 (2015): 174-8. doi: https://doi.org/10.4103/2278-330X.175954
Mallick S, Gandhi AK, Benson R, Sharma DN, Haresh KP, Gupta S, Julka PK, Rath GK. Outcomes of adult medulloblastoma treated with a multimodality approach: A tertiary cancer center experience. South Asian J Cancer. 2015 Oct-Dec;4(4):174-8. doi: 10.4103/2278-330X.175954. PMID: 26981508; PMCID: PMC4772394.
Copy Download .nbib Format: NLM
A case of Takotsubo cardiomyopathy after chemotherapy.

Oxford medical case reports

Malley T, Watson E.
PMID: 27066260
Oxf Med Case Reports. 2016 Apr 07;2016(4):55-8. doi: 10.1093/omcr/omw014. eCollection 2016 Apr.

Here we present the case of a patient with diffuse large B-cell lymphoma who was admitted to hospital for an elective autologous peripheral blood stem cell transplant after cytotoxic treatment with lomustine, cytarabine, cyclophosphomide and etoposide (LACE). On the...

Cite
Malley T, Watson E. A case of Takotsubo cardiomyopathy after chemotherapy. Oxf Med Case Reports. 2016;2016(4):55-8doi: 10.1093/omcr/omw014.
Malley, T., & Watson, E. (2016). A case of Takotsubo cardiomyopathy after chemotherapy. Oxford medical case reports, 2016(4), 55-8. https://doi.org/10.1093/omcr/omw014
Malley, Tamir, and Watson, Edmund. "A case of Takotsubo cardiomyopathy after chemotherapy." Oxford medical case reports vol. 2016,4 (2016): 55-8. doi: https://doi.org/10.1093/omcr/omw014
Malley T, Watson E. A case of Takotsubo cardiomyopathy after chemotherapy. Oxf Med Case Reports. 2016 Apr 07;2016(4):55-8. doi: 10.1093/omcr/omw014. eCollection 2016 Apr. PMID: 27066260; PMCID: PMC4823761.
Copy Download .nbib Format: NLM
Immune Reactivity and Pseudoprogression or Tumor Flare in a Serially Biopsied Neuroendocrine Patient Treated with the Epigenetic Agent RRx-001.

Case reports in oncology

Carter CA, Schmitz B, Peterson PG, Quinn M, Degesys A, Jenkins J, Oronsky B, Scicinski J, Caroen S, Reid TR, Cabrales P, Brzezniak C.
PMID: 27065848
Case Rep Oncol. 2016 Mar 10;9(1):164-70. doi: 10.1159/000444633. eCollection 2016.

Neuroendocrine tumors (NETs) are grouped together as a single class on the basis of histologic appearance, immunoreactivity for the neuroendocrine markers chromogranin A and synaptophysin, and potential secretion of hormones, neurotransmitters, neuromodulators and neuropeptides. Nevertheless, despite these common characteristics,...

Cite
Carter CA, Schmitz B, Peterson PG, et al. Immune Reactivity and Pseudoprogression or Tumor Flare in a Serially Biopsied Neuroendocrine Patient Treated with the Epigenetic Agent RRx-001. Case Rep Oncol. 2016;9(1):164-70doi: 10.1159/000444633.
Carter, C. A., Schmitz, B., Peterson, P. G., Quinn, M., Degesys, A., Jenkins, J., Oronsky, B., Scicinski, J., Caroen, S., Reid, T. R., Cabrales, P., & Brzezniak, C. (2016). Immune Reactivity and Pseudoprogression or Tumor Flare in a Serially Biopsied Neuroendocrine Patient Treated with the Epigenetic Agent RRx-001. Case reports in oncology, 9(1), 164-70. https://doi.org/10.1159/000444633
Carter, Corey A, et al. "Immune Reactivity and Pseudoprogression or Tumor Flare in a Serially Biopsied Neuroendocrine Patient Treated with the Epigenetic Agent RRx-001." Case reports in oncology vol. 9,1 (2016): 164-70. doi: https://doi.org/10.1159/000444633
Carter CA, Schmitz B, Peterson PG, Quinn M, Degesys A, Jenkins J, Oronsky B, Scicinski J, Caroen S, Reid TR, Cabrales P, Brzezniak C. Immune Reactivity and Pseudoprogression or Tumor Flare in a Serially Biopsied Neuroendocrine Patient Treated with the Epigenetic Agent RRx-001. Case Rep Oncol. 2016 Mar 10;9(1):164-70. doi: 10.1159/000444633. eCollection 2016. PMID: 27065848; PMCID: PMC4821155.
Copy Download .nbib Format: NLM
Biochemical remission by chemoradiotherapy in male mediastinal choriocarcinoma with diffuse lung metastasis: A case report.

Oncology letters

Zhang J, Wang ZJ, Yang B, Wei YY, Yang L, Hu Y, Hu YP.
PMID: 27073527
Oncol Lett. 2016 Apr;11(4):2615-2618. doi: 10.3892/ol.2016.4248. Epub 2016 Feb 18.

Primary mediastinal choriocarcinoma is a rare malignancy that is characterized by multiple metastases at the time of diagnosis, poor response to therapy and short survival times. There is no standard treatment for this disease. The present study described the...

Cite
Zhang J, Wang ZJ, Yang B, et al. Biochemical remission by chemoradiotherapy in male mediastinal choriocarcinoma with diffuse lung metastasis: A case report. Oncol Lett. 2016;11(4):2615-2618doi: 10.3892/ol.2016.4248.
Zhang, J., Wang, Z. J., Yang, B., Wei, Y. Y., Yang, L., Hu, Y., & Hu, Y. P. (2016). Biochemical remission by chemoradiotherapy in male mediastinal choriocarcinoma with diffuse lung metastasis: A case report. Oncology letters, 11(4), 2615-2618. https://doi.org/10.3892/ol.2016.4248
Zhang, Jing, et al. "Biochemical remission by chemoradiotherapy in male mediastinal choriocarcinoma with diffuse lung metastasis: A case report." Oncology letters vol. 11,4 (2016): 2615-2618. doi: https://doi.org/10.3892/ol.2016.4248
Zhang J, Wang ZJ, Yang B, Wei YY, Yang L, Hu Y, Hu YP. Biochemical remission by chemoradiotherapy in male mediastinal choriocarcinoma with diffuse lung metastasis: A case report. Oncol Lett. 2016 Apr;11(4):2615-2618. doi: 10.3892/ol.2016.4248. Epub 2016 Feb 18. PMID: 27073527; PMCID: PMC4812108.
Copy Download .nbib Format: NLM
Claudin 1 Promotes Migration and Increases Sensitivity to Tamoxifen and Anticancer Drugs in Luminal-like Human Breast Cancer Cells MCF7.

Cancer investigation

Zhou B, Blanchard A, Wang N, Ma X, Han J, Schroedter I, Leygue E, Myal Y.
PMID: 26279089
Cancer Invest. 2015 Aug 17; Epub 2015 Aug 17.

Downregulation of claudin 1, a critical tight junction protein, has been correlated with increased invasiveness in breast cancer. However, recent studies suggest that claudin 1 contributes to the progression of some molecular subtypes of breast cancer. In this study,...

Cite
Zhou B, Blanchard A, Wang N, et al. Claudin 1 Promotes Migration and Increases Sensitivity to Tamoxifen and Anticancer Drugs in Luminal-like Human Breast Cancer Cells MCF7. Cancer Invest. 2015;
Zhou, B., Blanchard, A., Wang, N., Ma, X., Han, J., Schroedter, I., Leygue, E., & Myal, Y. (2015). Claudin 1 Promotes Migration and Increases Sensitivity to Tamoxifen and Anticancer Drugs in Luminal-like Human Breast Cancer Cells MCF7. Cancer investigation, .
Zhou, Bowen, et al. "Claudin 1 Promotes Migration and Increases Sensitivity to Tamoxifen and Anticancer Drugs in Luminal-like Human Breast Cancer Cells MCF7." Cancer investigation vol. (2015).
Zhou B, Blanchard A, Wang N, Ma X, Han J, Schroedter I, Leygue E, Myal Y. Claudin 1 Promotes Migration and Increases Sensitivity to Tamoxifen and Anticancer Drugs in Luminal-like Human Breast Cancer Cells MCF7. Cancer Invest. 2015 Aug 17; Epub 2015 Aug 17. PMID: 26279089.
Copy Download .nbib Format: NLM
Chemotherapy-induced endometrial pathology: mimicry of malignancy and viral endometritis.

American journal of translational research

Kim EK, Yoon G, Kim HS.
PMID: 27347355
Am J Transl Res. 2016 May 15;8(5):2459-67. eCollection 2016.

Chemotherapy is a common type of preoperative neoadjuvant treatment and postoperative adjuvant or palliative therapy for many different types of malignancies. Certain chemotherapeutic agents can induce bizarre epithelial atypia that mimics malignancy. Unfamiliarity with these changes could potentially cause...

Cite
Kim EK, Yoon G, Kim HS. Chemotherapy-induced endometrial pathology: mimicry of malignancy and viral endometritis. Am J Transl Res. 2016;8(5):2459-67
Kim, E. K., Yoon, G., & Kim, H. S. (2016). Chemotherapy-induced endometrial pathology: mimicry of malignancy and viral endometritis. American journal of translational research, 8(5), 2459-67.
Kim, Eun Kyung, et al. "Chemotherapy-induced endometrial pathology: mimicry of malignancy and viral endometritis." American journal of translational research vol. 8,5 (2016): 2459-67.
Kim EK, Yoon G, Kim HS. Chemotherapy-induced endometrial pathology: mimicry of malignancy and viral endometritis. Am J Transl Res. 2016 May 15;8(5):2459-67. eCollection 2016. PMID: 27347355; PMCID: PMC4891460.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 1811 entries